Package 33342-277-12

{"route": ["ORAL"], "spl_id": "2abbe156-e5ab-484c-aed7-fa4b5f06698d", "openfda": {"upc": ["0333342277077", "0333342276070", "0333342277107", "0333342276100"], "unii": ["CR02EYQ8GV"], "rxcui": ["485421", "485423"], "spl_set_id": ["7ae60119-e22c-4806-a5d8-db7c9e8984a2"], "manufacturer_name": ["Macleods Pharmaceuticals Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE (33342-277-07)", "package_ndc": "33342-277-07", "marketing_start_date": "20170729"}, {"sample": false, "description": "90 TABLET, EXTENDED RELEASE in 1 BOTTLE (33342-277-10)", "package_ndc": "33342-277-10", "marketing_start_date": "20170729"}, {"sample": false, "description": "10 BLISTER PACK in 1 CARTON (33342-277-12)  / 10 TABLET, EXTENDED RELEASE in 1 BLISTER PACK", "package_ndc": "33342-277-12", "marketing_start_date": "20170729"}], "brand_name": "Darifenacin", "product_id": "33342-277_2abbe156-e5ab-484c-aed7-fa4b5f06698d", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Cholinergic Muscarinic Antagonist [EPC]", "Cholinergic Muscarinic Antagonists [MoA]"], "product_ndc": "33342-277", "generic_name": "Darifenacin", "labeler_name": "Macleods Pharmaceuticals Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Darifenacin", "active_ingredients": [{"name": "DARIFENACIN HYDROBROMIDE", "strength": "15 mg/1"}], "application_number": "ANDA207302", "marketing_category": "ANDA", "marketing_start_date": "20170729", "listing_expiration_date": "20261231"}